Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Adjuvant chemotherapy with high-dose cyclophosphamide, etoposide and cisplatin intensification without progenitor cell support in breast cancer patients with ten or more involved nodes: 5-year results of a pilot trial.
Ballestrero A, Rubagotti A, Stura P, Ferrando F, Amoroso D, Rinaldini M, Sismondi P, Genta F, Mesiti M, Brema F, Patrone F, Boccardo F; GROCTA (Italian Breast Cancer Adjuvant Study). Ballestrero A, et al. Among authors: brema f. Oncology. 2001;60(3):221-7. doi: 10.1159/000055322. Oncology. 2001. PMID: 11340373
Phase-II study of Navelbine in advanced breast cancer.
Canobbio L, Boccardo F, Pastorino G, Brema F, Martini C, Resasco M, Santi L. Canobbio L, et al. Among authors: brema f. Semin Oncol. 1989 Apr;16(2 Suppl 4):33-6. Semin Oncol. 1989. PMID: 2711204 No abstract available.
Paclitaxel plus ifosfamide in advanced ovarian cancer: a multicenter phase II study.
Miglietta L, Amoroso D, Bruzzone M, Granetto C, Catsafados E, Mammoliti S, Guarneri D, Pedulla F, Foglia G, Ragni N, Martini MC, Brema F, Addamo G, Moraglio L, Pastorino G, Boccardo F. Miglietta L, et al. Among authors: brema f. Oncology. 1997 Mar-Apr;54(2):102-7. doi: 10.1159/000227671. Oncology. 1997. PMID: 9075779 Clinical Trial.
High-dose mitoxantrone with peripheral blood progenitor cell rescue: toxicity, pharmacokinetics and implications for dosage and schedule.
Ballestrero A, Ferrando F, Garuti A, Basta P, Gonella R, Esposito M, Vannozzi MO, Sorice G, Friedman D, Puglisi M, Brema F, Mela GS, Sessarego M, Patrone F. Ballestrero A, et al. Among authors: brema f. Br J Cancer. 1997;76(6):797-804. doi: 10.1038/bjc.1997.465. Br J Cancer. 1997. PMID: 9310249 Free PMC article. Clinical Trial.
42 results